HUTCHMED (China) Ltd (ADR)
General ticker "HCM" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $14.1B
HUTCHMED (China) Ltd (ADR) follows the US Stock Market performance with the rate: 25.9%.
Estimated limits based on current volatility of 1.3%: low 13.97$, high 14.33$
Factors to consider:
- Earnings for 18 months up through Q2 (+1 year) exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2022-12-31 to 2024-12-30
- 2022-12-31 to 2023-12-31 estimated range: [8.05$, 16.84$]
- 2023-12-31 to 2024-12-30 estimated range: [7.17$, 15.22$]
Financial Metrics affecting the HCM estimates:
- Negative: Non-GAAP EPS, $ of -1.29 <= 0.10
- Negative: Operating profit margin, % of -49.01 <= 1.03
- Negative: negative Net income
- Negative: Operating cash flow per share per price, % of -2.30 <= 2.35
- Positive: Interest expense per share, $ of 0 <= 0.14
Short-term HCM quotes
Long-term HCM plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 |
|---|---|---|
| Operating Revenue | $356.13MM | $426.41MM |
| Operating Expenses | $692.59MM | $836.18MM |
| Operating Income | $-336.46MM | $-409.77MM |
| Non-Operating Income | $120.72MM | $-0.65MM |
| Interest Expense | $0.59MM | $0.65MM |
| R&D Expense | $207.45MM | $267.59MM |
| Income(Loss) | $-215.74MM | $-410.42MM |
| Taxes | $11.92MM | $-0.28MM |
| Profit(Loss) | $-227.66MM | $-410.14MM |
| Stockholders Equity | $986.89MM | $610.37MM |
| Inventory | $35.76MM | $56.69MM |
| Assets | $1,372.66MM | $1,029.44MM |
| Operating Cash Flow | $-204.22MM | $-268.60MM |
| Capital expenditure | $16.76MM | $36.66MM |
| Investing Cash Flow | $-306.32MM | $296.59MM |
| Financing Cash Flow | $650.03MM | $-82.76MM |
| Earnings Per Share* | $-0.29 | $-0.48 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.